Japanese Orthopedic Biomaterials Market Expected to Approach $1.5 Million By 2019

The report “Japanese Orthopedic Biomaterials Market″ by Publisher Name is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with (Japanese Orthopedic Biomaterials Market) / Japanese Orthopedic Biomaterials Market in subject line and your contact details to purchase this report or get your questions answered.

The collection of ‘Biomaterials’ market research reports has a new addition of “Japanese Orthopedic Biomaterials Market” on RnRMarketResearch.com The Japanese orthopedic biomaterials market is expected to approach $1.5 billion by 2019. The hyaluronic acid viscosupplementation segment is expected to constitute the majority of the Japanese orthopedic biomaterials market.

The orthopedic biomaterials market comprises autologous bone grafts, bone graft substitutes (segmented only into synthetics) and hyaluronic acid (HA) viscosupplementation. Although the market has reached maturity in Japan, it is expected to continue to grow as a result of the large aging population. Further growth in the overall market will be fuelled by the increased value of the HA viscosupplementation segment. This is due to the continued use of premium priced three-injection cycle products in Japan that were introduced in December 2010.

Buy a copy of this report by iData Research @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103722.

Scope: This report pertains to a forecast period of 10 years (2009 – 2019) for Japan.

Report Contents:

Competitor Analysis, Identified Strategic Opportunities, Market Overview by Segment & Country, Trend Analysis by Segment & Country, Market Drivers & Limiters, Mergers & Acquisitions, Customer Feedback and Market Monitoring

Main Markets Included:

Bone Graft Substitute, Hyaluronic Acid Viscosupplementation

Sub-Segments Included:

Autograft, Non-Proprietary Allograft, Synthetic Allograft, Demineralized Bone Matrix, Cervical Spine, Thoracolumbar Spine, Trauma & Reconstruction, Craniomaxillofacial, Single-injection products, Three-injection cycle products, Five-injection cycle products

Complete report spread across [94] pages OR having X Data Tables and Y Figures available @ http://www.rnrmarketresearch.com/japanese-orthopedic-biomaterials-market-market-report.html. Read more on “Japanese Orthopedic Biomaterials Market” report below.

Companies Included:

Seikagaku (Kaken), Chugai Genzyme (Teijin), Maruho, Meiji Seika Kaisha, Taisho, Olympus, Terumo, Hoya/Pentax, Japan Medicalnext, Kyocera Medical

Others include: Biomet, JMDM, Mizuho, NGKNTK, Stryker, Zimmer and local Japanese pharmaceutical companies.

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

For further information on “Japanese Orthopedic Biomaterials Market” report OR for any other business research / market intelligence need on the ‘Biotechnology’ market (‘Biomaterials’ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/biomaterials), contact sales@rnrmarketresearch.com / Call +1 888 391 5441.